The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia
Abstract
Background The Calgary Depression Scale for Schizophrenia (CDSS) is a valid tool to assess depression in schizophrenics and has been translated, adapted, and validated to be used in different non-English languages. Therefore, it may be predicted that a Spanish version of this scale will be also a valid instrument to assess symptoms of depression in patients with schizophrenia.Objective We determined the validity of the Spanish version of the Calgary scale (CDSS-S).Methods Outpatients and inpatients (n=93) diagnosed as having schizophrenia by DSM-IV criteria confirmed by SCID-IV interview were included. The Positive and Negative Syndrome Scale (PANSS), Hamilton Depression Rating Scale (HDRS-17 and HDRS-21 items), Montgomery-Asberg Depression Rating Scale (MADRS), Extrapyramidal Symptoms Rating Scale (ESRS), and Barnes Acathisia Rating Scale were administered by a first rater, whereas the CDSS-S was assessed by a second independent rater.Results The internal consistency (Cronbach's alpha 0.83) and the interrater reliability (>0.73 intraclass correlation coefficient [ICC] for single items and 0.92 for total score) were good. The test-retest reliability was high (ICC of 0.89). The scale showed a good construct validity with statistically significant correlations with HDRS-17, HDRS-21, MADRS, and G6 item (depression) of PANSS. The CDSS showed no correlation with the positive subscale of PANSS and a weak correlation with the negative subscale, general psychopathology subscale, and total score of PANSS. A cut point of five showed 94.7% sensitivity, 86.5% specificity, and 70% and 98% positive and negative predictive values, respectively.Conclusions The Spanish version of CDSS is a valid instrument to assess depressive episodes for stabilized and acute patients with schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Spanish version of CDSS has high internal consistency (Cronbach’s alpha = 0.83) and high inter-rater reliability (ICC > 0.70); it also discriminates between depressed and non-depressed people with SSD [41].”
Citations
Cites
Coefficient Alpha and the Internal Structure of Tests
Cronbach, L. J. (1951) · Psychometrika · doi:10.1007/bf02310555 · Cited by 43,931
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Rozeboom, W. W., Lord, F. M., Novick, M. R., & Birnbaum, A. (1969) · American Educational Research Journal · doi:10.2307/1162101 · Cited by 8,012
Book Review: Measurement and Classification of Psychiatric Symptoms
Priest, R. G. (1975) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577506800751 · Cited by 2,268
A Rating Scale for Drug-Induced Akathisia
Barnes, T. R. E. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,179
The statistical power of abnormal-social psychological research: A review.
Cohen, J. (1962) · The Journal of Abnormal and Social Psychology · doi:10.1037/h0045186 · Cited by 1,824
A depression rating scale for schizophrenics
Addington, D. E., Addington, J., & Schıssel, B. (1990) · Schizophrenia Research · doi:10.1016/0920-9964(90)90005-r · Cited by 1,270
Assessing Depression in Schizophrenia: The Calgary Depression Scale
Addington, D. E., Addington, J., & Maticka‐Tyndale, E. (1993) · The British Journal of Psychiatry · doi:10.1192/s0007125000292581 · Cited by 1,177
Cited by
Sorted by citations
A systematic review of instruments to measure depressive symptoms in patients with schizophrenia
Lako, I. M., Bruggeman, R., Knegtering, H., Wiersma, D., Schoevers, R. A., Slooff, C. J., & Taxis, K. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.014 · Cited by 154
Addington, J., Shah, H., Liu, L., & Addington, D. E. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.12.014 · Cited by 121
Majadas, S., Olivares, J. M., Galan, J., & Díez, T. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2011.03.009 · Cited by 104
Predictors of Relapse and Functioning in First-Episode Psychosis: A Two-Year Follow-Up Study
Bergé, D., Mané, A., Salgado, P., Cortizo, R., Garnier, C., Gomez, L., Diez-Aja, C., Bulbena, A., & Pérez, V. (2016) · Psychiatric Services · doi:10.1176/appi.ps.201400316 · Cited by 96
Diagnostic validity of assessment scales for depression in patients with schizophrenia
Kim, S.-W., Kim, S.-J., Yoon, B.-H., Kim, J.-M., Shin, I.-S., Hwang, M. Y., & Yoon, J.-S. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.10.002 · Cited by 88
García‐Rizo, C., Fernández-Egea, E., Oliveira, C., Justicia, A., Parellada, E., Bernardo, M., & Kirkpatrick, B. W. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.025 · Cited by 91
van Rooijen, G., Isvoranu, A., Kruijt, O. H., van Borkulo, C. D., Meijer, C. J., Wigman, J. T. W., Ruhé, H. G., de Haan, L., Bruggeman, R., Cahn, W., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.035 · Cited by 80
Augmentation with antidepressants in schizophrenia treatment: benefit or risk
Zhang, M., & Mao, Y. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s62266 · Cited by 65
Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS)
Valiente-Gómez, A., Mezquida, G., Romaguera, A., Vilardebò, I., Andrés, H., Granados, B., Larrubia, J., Pomarol‐Clotet, E., McKenna, P. J., Sarró, S., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.006 · Cited by 57
Self-citationEdwards, C. J., Garety, P., & Hardy, A. (2019) · Psychological Medicine · doi:10.1017/s0033291719002381 · Cited by 54
Lu, S.-F., Lo, C. K., Sung, H., Hsieh, T., Yu, S.-C., & Chang, S. (2013) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2013.09.002 · Cited by 53
Schennach, R., Obermeier, M., Seemüller, F., Jäger, M., Schmauß, M., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L., Gäebel, W., et al. (2012) · Psychopathology · doi:10.1159/000336729 · Cited by 53
The role of NGF and IL-2 serum level in assisting the diagnosis in first episode schizophrenia
Xiong, P., Zeng, Y., Wan, J., XiaoHan, D. H., Tan, D., Lü, J., Xu, F., Li, H. Y., Zhu, Z., & Ma, M. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.12.017 · Cited by 52
Ochoa, S., Haro, J. M., Huerta‐Ramos, E., Cuevas‐Esteban, J., Stephan‐Otto, C., Usall, J., Nieto, L. L., & Brébion, G. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.026 · Cited by 48
Regnault, A., & Herdman, M. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0722-8 · Cited by 47
Kim, Y. K., Won, S. D., Lee, K. M., Choi, H. S., Jang, H. S., Lee, B. H., & Möller, H. (2005) · 신경정신의학 · Cited by 44
Blood cell count in antipsychotic-naive patients with non-affective psychosis
Garcia‐Rizo, C., Casanovas, M., Fernandez‐Egea, E., Oliveira, C., Meseguer, A., Cabrera, B., Mezquida, G., Bioque, M., Kirkpatrick, B., & Bernardo, M. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12456 · Cited by 43
Reliability and Validity of the Chinese Version of the Calgary Depression Scale for Schizophrenia
Xiao, W., Liu, H., Zhang, H., Liu, Q., Fu, P.-X., Chen, J., Wang, X., Wang, G., Li, L., & Shu, L. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670902873672 · Cited by 39
Müller, M. J., Brening, H., Gensch, C., Klinga, J., Kienzle, B., & Müller, K.-M. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.04.005 · Cited by 37
Insight and suicidality in psychosis: A cross-sectional study
Massons, C., Lopez-Morinigo, J.-D., Pousa, E., Ruiz, A., Ochoa, S., Usall, J., Nieto, L., Cobo, J., David, A. S., & Dutta, R. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.059 · Cited by 36
Fusté, M., Pinacho, R., Meléndez-Pérez, I., Villalmanzo, N., Villalta‐Gil, V., Haro, J. M., & Ramos, B. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.07.019 · Cited by 33
González-Blanco, L., García‐Portilla, M. P., Santo, F. D., García-Álvarez, L., de la Fuente-Tomás, L., Menéndez-Miranda, I., Bobes-Bascarán, T., Sáiz, P. A., & Bobes, J. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112509 · Cited by 33
Schizophrenia: Measurements of Psychopathology
Lindenmayer, J., Harvey, P. D., Khan, A., & Kirkpatrick, B. W. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.04.005 · Cited by 33
18FDG PET study of amygdalar activity during facial emotion recognition in schizophrenia
Fernández-Egea, E., Parellada, E., Lomeña, F., Falcón, C., Pavı́a, J., Mané, A., Horga, G., & Bernardo, M. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0020-6 · Cited by 32
van Rooijen, G., van Rooijen, M., Maat, A., Vermeulen, J. M., Meijer, C. J., Ruhé, H. G., de Haan, L., Alizadeh, B. Z., Bartels‐Velthuis, A. A., van Beveren, N. J. M., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.04.011 · Cited by 27
Reyes, M. M., Quiñones, R. M., Domínguez, M., Caballero, A., Bravo, T. M., Díaz, T., Gerra, S., Ibáñez, A. M., & Ruiz‐Linares, A. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.11.026 · Cited by 27
How Hyperprolactinemia Affects Sexual Function in Patients Under Antipsychotic Treatment
Rubio‐Abadal, E., Cacho, N. D., Saenz-Navarrete, G., Arranz, B., Cambra, R. M., Cuadras, D., Rodante, D., Fehér, C., Roca, M., Barneda, V., et al. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000539 · Cited by 27
Validity and Reliability of the Arabic Version of the Positive and Negative Syndrome Scale
Yehya, A., Ghuloum, S., Mahfoud, Z. R., Opler, M. G., Khan, A., Hammoudeh, S., Abdulhakam, A., Al-Mujalli, A., Hani, Y., Elsherbiny, R., et al. (2016) · Psychopathology · doi:10.1159/000447328 · Cited by 25
Validation of the Arabic Version of Calgary Depression Scale for Schizophrenia
Hani, Y., Ghuloum, S., Mahfoud, Z. R., Opler, M. G. A., Khan, A., Yehya, A., Abdulhakam, A., Hammoudeh, S., Al-Mujalli, A., Elsherbiny, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162304 · Cited by 24
Biomarcadores de estrés oxidativo y dimensiones clínicas en los 10 primeros años de esquizofrenia
González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., Rodríguez‐González, S., Coto‐Montes, A. M., & Bobes, J. (2018) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2018.03.003 · Cited by 23
Mauriño, J., Mauriño, J., & Díez, T. (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s24479 · Cited by 22
Crespo‐Facorro, B., Bernardo, M., Argimón, J. M., Arrojo, M., Bravo‐Ortiz, M. F., Cabrera-Cifuentes, A., Román, J. C., Franco, M., García‐Portilla, M. P., Haro, J. M., et al. (2016) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2016.09.001 · Cited by 28
Rekhi, G., Ng, W. Y., & Lee, J. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.06.056 · Cited by 21
Calderon-Mediavilla, M., Vila‐Badia, R., Dolz, M., Butjosa, A., Barajas, A., Cacho, N. D., Sánchez, B., Pardo, M., Baños, I., Usall, J., et al. (2020) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-020-01618-0 · Cited by 21
Siddi, S., Núñez, C., Senior, C., Preti, A., Cuevas‐Esteban, J., Ochoa, S., Brébion, G., & Stephan‐Otto, C. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.12.001 · Cited by 20
Depression: An actionable outcome for those at clinical high-risk
Addington, J., Farris, M. S., Liu, L., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.10.001 · Cited by 18
Reliability of the Calgary depression scale for schizophrenia: A meta-analysis
Porter, L., Jones, C. A., & Fox, A. P. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.11.040 · Cited by 18
Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia
González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., Rodríguez‐González, S., Coto‐Montes, A. M., & Bobes, J. (2018) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2018.03.001 · Cited by 18
Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms
García‐Portilla, M. P., García-Álvarez, L., González-Blanco, L., Santo, F. D., Bobes-Bascarán, T., Martínez-Cao, C., García-Fernández, A., Sáiz, P. A., & Bobes, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.700747 · Cited by 18
Villalta‐Gil, V., Meléndez-Pérez, I., Russell, T. A., Surguladze, S., Raduà, J., Fusté, M., Stephan‐Otto, C., & Haro, J. M. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.06.020 · Cited by 16
The association of clinical insight and depression with quality of life in schizophrenia
Arrarás, J. I., Ibáñez, B., Pereda, N., Iribarren, S., & Basterra, I. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.02.069 · Cited by 15
Grover, S., Sahoo, S., Nehra, R., Chakrabarti, S., & Avasthi, A. (2017) · International Journal of Social Psychiatry · doi:10.1177/0020764017691314 · Cited by 14
Diago, M., Vila‐Badia, R., Serra‐Arumí, C., Butjosa, A., Cacho, N. D., Esteban‐Sanjusto, M., Colomer-Salvans, A., Sánchez, L., Dolz, M., Muñoz‐Samons, D., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114699 · Cited by 17
The Psychosocial Impact of Insight Paradox and Internalized Stigma in Chronic Psychotic Disorders
García, J. J. M., Hodann-Caudevilla, R. M., Castaño, A. G., Garrido, S. A., Tischhauser, R. D., Rada, Á. P., & Salom, R. (2025) · Behavioral Sciences · doi:10.3390/bs15040410 · Cited by 16
Vargas, T., Ahmed, A. O., Strauss, G. P., Brandes, C. M., Walker, E. F., Buchanan, R. W., Gold, J. M., & Mittal, V. A. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0563-x · Cited by 15
Crespo‐Facorro, B., Bernardo, M., Argimón, J. M., Arrojo, M., Bravo‐Ortiz, M. F., Cabrera-Cifuentes, A., Román, J. C., Franco, M., García‐Portilla, M. P., Haro, J. M., et al. (2017) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2016.09.002 · Cited by 13
González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., & Bobes, J. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.042 · Cited by 12
Paniagua, G., Couce-Sánchez, M., González-Blanco, L., Sabater, C., García-Fernández, A., Rodríguez-Revuelta, J., Sáiz, P. A., Bobes, J., Margollés, A., & García‐Portilla, M. P. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111345 · Cited by 13
Santo, F. D., González-Blanco, L., García-Álvarez, L., de la Fuente-Tomás, L., Velasco, Á., Alvarez-Vázquez, C., Martínez-Cao, C., Sáiz, P. A., García‐Portilla, M. P., & Bobes, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-73043-x · Cited by 12
Bigseth, T. T., Engh, J. A., Egeland, J., Andersen, E., Andreassen, O. A., Bang-Kittilsen, G., Falk, R. S., Holmen, T. L., Lindberg, M., Mordal, J., et al. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03522-6 · Cited by 11
González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., Rodríguez‐González, S., Coto‐Montes, A. M., & Bobes, J. (2018) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2018.03.004 · Cited by 10
Alonso, Y., Miralles, C., Algora, M. J., Valiente-Pallejà, A., Sánchez‐Gistau, V., Muntané, G., Labad, J., Vilella, E., & Martorell, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-15479-x · Cited by 10
Culture and Psychosis in Clinical Practice
Jarvis, G. E., Iyer, S. N., Andermann, L., & Fung, K. P.-L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815012-2.00004-3 · Cited by 10
Vila‐Badia, R., Kaplan, M. I., Butjosa, A., Cacho, N. D., Serra‐Arumí, C., Colomer-Salvans, A., Esteban‐Sanjusto, M., Iglesias-González, M., Cuñat, O., Hoyo, B., et al. (2022) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2716 · Cited by 13
A continuous emotional task activates the left amygdala in healthy volunteers: 18FDG PET study
Fernández-Egea, E., Parellada, E., Lomeña, F., Falcón, C., Pavı́a, J., Mané, A., Sugranyes, G., Valdes, M., & Bernardo, M. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.01.003 · Cited by 10
López-Moríñigo, J.-D., Martínez, A. S.-E., Barrigón, M. L., Escobedo-Aedo, P. J., Ruiz-Ruano, V. G., Sánchez-Alonso, S., Mata-Iturralde, L., Muñoz-Lorenzo, L., Cuadras, D., Ochoa, S., et al. (2023) · Schizophrenia · doi:10.1038/s41537-022-00316-x · Cited by 9
Ahuir, M., Crosas, J. M., Estrada, F., Zabala, W., Pérez-Muñoz, S., González-Fernández, A., Tost, M., Aguayo, R., Montalvo, I., Miñano, M. J., et al. (2020) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2020.07.005 · Cited by 9
Fraguas, D., Díaz‐Caneja, C. M., Pina‐Camacho, L., Rossum, I. W.-V., Baandrup, L., Sommer, I. E., Glenthoj, B. Y., Kahn, R. S., Leucht, S., & Arango, C. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.03.010 · Cited by 9
The relevance of processing speed in the functioning of people with first-episode psychosis
Abella, M., Vila‐Badia, R., Serra‐Arumí, C., Vallejo-Rius, G., Colomer-Salvans, A., Rolduà‐Ros, J., Cacho, N. D., Butjosa, A., Muñoz‐Samons, D., Cuevas‐Esteban, J., et al. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.02.014 · Cited by 9
Wolpe, N., Perrottelli, A., Giuliani, L., Yang, Z., Rekhi, G., Jones, P. B., Bernardo, M., García‐Portilla, M. P., Kaiser, S., Robert, G., et al. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.12.016 · Cited by 8
Monsonet, M., Kwapil, T. R., & Barrantes‐Vidal, N. (2021) · Assessment · doi:10.1177/1073191120986622 · Cited by 7
Navarra‐Ventura, G., Vicent-Gil, M., Serra-Blasco, M., Cobo, J., Fernández‐Gonzalo, S., Goldberg, X., Jódar, M., Crosas, J. M., Palao, D. J., Lahera, G., et al. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01265-9 · Cited by 9
Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?
González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., Rodríguez‐González, S., Coto‐Montes, A. M., & Bobes, J. (2019) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2018.03.003 · Cited by 7
The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P)
Rostami, R., Kazemi, R., Ardakani, M. R. K., Sohrabi, L., Ghiasi, S., Kamali, Z. S., Zaryabi, A., Ghiasi, Z., Nasiri, Z., Rezaei, M., et al. (2019) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2019.08.017 · Cited by 7
Acosta, F. J., Navarro, S., Cabrera, B., Ramallo‐Fariña, Y., & Martínez, N. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.03.042 · Cited by 9
Herniman, S. E., Cotton, S., Allott, K., Phillips, L., Wood, S. J., Liemburg, E. J., Castelein, S., Veling, W., Bruggeman, R., & Knegtering, H. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.12.015 · Cited by 7
Peraire, M., Arnau, F., Benito, A., Fuertes-Sáiz, A., Almodóvar-Fernández, I., & Haro, G. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111090 · Cited by 6
El-Bahy, M., & Mohamed, W. M. Y. (2013) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000433781.14841.77 · Cited by 6
Mediavilla, R., Muñoz-Sanjose, A., Rodriguez-Vega, B., Bayon, C., Palao, A., Lahera, G., Sanchez-Castro, P., Roman, E., Cebolla, S., de Diego, A., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2206-4 · Cited by 5
“70); it also discriminates between depressed and non-depressed people with SSD [41].”
BackgroundInfluentialMartínez-Cao, C., García-Fernández, A., González-Blanco, L., Sáiz, P. A., Bobes, J., & García‐Portilla, M. P. (2024) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2024.100317 · Cited by 6
Insight and illness perception in Mexican patients with psychosis
Gómez-de-Regil, L. (2015) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2015.01.002 · Cited by 5
Martínez-Cao, C., García-Álvarez, L., Bobes-Bascarán, T., de la Fuente-Tomás, L., Fernández-Egea, E., Velasco, Á., González-Blanco, L., Madera, P. Z., Fonseca‐Pedrero, E., Sáiz, P. A., et al. (2020) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2020.04.008 · Cited by 5
Psychometric Properties of the Montgomery-Åsberg Depression Rating Scale in Severely Obese Patients
Paiva-Medeiros, P., Duarte-Guerra, L. S., Santo, M. A., Neto, F. L., & Wang, Y. (2015) · The Spanish Journal of Psychology · doi:10.1017/sjp.2015.072 · Cited by 5
Diagnostic features of the cycloid psychoses in a first psychotic episode sample
García-Andrade, R. F., Díaz‐Marsá, M., Carrasco, J. L., Lopez-Micó, C., Saiz-González, D., Aurecoechea, J. F., Yanez, R., & López-Ibor, J. J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.10.023 · Cited by 5
Arranz, S., Camacho, J., Andrés, C., Niubó, I., & Sánchez‐Gistau, V. (2019) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2019.03.004 · Cited by 4
Martínez-Cao, C., Lasheras, F. S., García-Fernández, A., González-Blanco, L., Madera, P. Z., Sáiz, P. A., Bobes, J., & García‐Portilla, M. P. (2024) · European Psychiatry · doi:10.1192/j.eurpsy.2024.17 · Cited by 3
Rahim, T. A., Al‐Salihy, Z., & Mahmood, M. Q. (2014) · The Arab Journal of Psychiatry · doi:10.12816/0004112 · Cited by 3
Randomised controlled trial of clozapine in resistant schizophrenia and schizoaffective disorder
Peraire, M., Arnau, F., Villar-García, M., Benito, A., Echeverria, I., & Haro, G. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251355602 · Cited by 3
Novitsky, M. A., St. Petersburg, R. F., Shnayder, N. A., Bugay, V., & Nasyrova, R. F. (2021) · Doctor Ru · doi:10.31550/1727-2378-2021-20-5-55-61 · Cited by 3
Catatonia in first-episode psychosis: prevalence and psychopathological association
Cuevas‐Esteban, J., Serrat, F., Iglesias-González, M., Motta, N., Jiménez-Fernández, B., Vila‐Badia, R., Colomer-Salvans, A., Serra‐Arumí, C., Cacho, N. D., Corbella-Sotil, A., et al. (2025) · BJPsych Open · doi:10.1192/bjo.2025.10834 · Cited by 2
López-Moríñigo, J.-D., Fraguas, D., Díaz‐Caneja, C. M., Galvañ, J., Berger, G. E., Leucht, S., Rossum, I. W.-V., Arango, C., & Moreno, C. (2025) · Schizophrenia · doi:10.1038/s41537-025-00681-3 · Cited by 2
Ahuir, M., Crosas, J. M., Estrada, F., Zabala, W., Pérez-Muñoz, S., González-Fernández, A., Tost, M., Aguayo, R., Montalvo, I., Miñano, M. J., et al. (2021) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2021.03.004 · Cited by 2
Negative symptoms in drug-naive patients with a first-episode psychosis (FEP)
Cuñat, O., Hoyo, B., Vila‐Badia, R., Serra‐Arumí, C., Butjosa, A., Cacho, N. D., Colomer-Salvans, A., Dolz, M., Cuevas‐Esteban, J., Iglesias-González, M., et al. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103448 · Cited by 2
Martínez-Cao, C., García-Álvarez, L., Bobes-Bascarán, T., de la Fuente-Tomás, L., Fernández-Egea, E., Velasco, Á., González-Blanco, L., Madera, P. Z., Fonseca‐Pedrero, E., Sáiz-Martínez, P. A., et al. (2022) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2020.04.007 · Cited by 2
Martínez-Cao, C., García-Fernández, A., González-Blanco, L., Madera, P. Z., Sáiz, P. A., García‐Portilla, M. P., & Bobes, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1181758 · Cited by 1
Pena-Garijo, J., Masanet, M. J., Palop-Grau, A., & Lacruz, M. (2026) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2025.100416 · Cited by 1
Guzmán-González, H., Bernal-Santos, R., Morales-Martínez, C. E., & Rosel-Vales, M. (2026) · Cureus · doi:10.7759/cureus.106527 · Cited by 1
Sensibilidad en el Reconocimiento de Emociones Faciales Como Endofenotipo de Esquizofrenia
Quintero, C., Valencia, J. G., Muñoz, C., Rangel, A., Palacio, C., Ospina-Duque, J., Arango-Viana, J. C., Aguirre–Acevedo, D. C., Ocampo, M. V., Valencia, A., et al. (2015) · Revista Colombiana de Psicología · doi:10.15446/rcp.v24n1.41738 · Cited by 1
Comparison between a morocco and a native-born population, in a sample of first episode psychosis
Arranz, S., Camacho, J., Andrés, C., Niubó, I., & Sánchez‐Gistau, V. (2020) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2020.07.002 · Cited by 1
Depressive symptoms among patients with schizophrenia in acute and remission phases
Peljto, A., Pešić, D., Christodoulou, G. N., & Lečić‐Toševski, D. (2017) · Vojnosanitetski pregled · doi:10.2298/vsp160311004p
Guerra, L. S. D. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-23052019-155025
González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., Santo, F. D., de la Fuente-Tomás, L., Rodríguez-Revuelta, J., Velasco, Á., Alvarez-Vázquez, C., Sáiz, P. A., & Bobes, J. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.581
Ochoa, S., Espinosa, V., López‐Carrilero, R., Martinez, I., Barrera, A. D. H., Birulés, I., Barajas, A., Peláez, T., Díaz-Cutraro, L., Coromina, M., et al. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1359693 · Cited by 2
Llaurador-Coll, M., Cabezas, Á., Algora, M. J., Solé, M., Vilella, E., & Sánchez‐Gistau, V. (2024) · Schizophrenia · doi:10.1038/s41537-024-00521-w
Resilience in people with first-episode psychosis: The relevance of depression
Serra‐Arumí, C., Vila‐Badia, R., Colomer-Salvans, A., Cacho, N. D., Butjosa, A., Abella, M., Rolduà‐Ros, J., Cuautle, A., Fernández-Sanz, A., Cuevas‐Esteban, J., et al. (2025) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2025.151853
Social Cognition in Suicidal Behavior in Psychosis: A Systematic Review
Herrero, M. C., Sastre-Buades, A., & Barrigón, M. L. (2025) · Behavioral Sciences · doi:10.3390/bs15060759
Childhood sexual abuse in first-episode psychosis: The relevance in cognitive bias
Vila‐Badia, R., Espinosa, V., Colomer-Salvans, A., Serra‐Arumí, C., Corbella-Sotil, A., Cacho, N. D., Butjosa, A., Ochoa, S., Cuevas‐Esteban, J., Muñoz‐Samons, D., et al. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.07.004
Luna-Padilla, J. A., Ruiz‐Contreras, A. E., Flores-Medina, Y., Rosel-Vales, M., Celada-Borja, C., Fernández, J. P., Twamley, E. W., & Mondragón‐Maya, A. (2025) · Applied Neuropsychology Adult · doi:10.1080/23279095.2025.2558171
Llaurador-Coll, M., Montalvo, I., Estrada, F., Sánchez‐Gistau, V., Zetterberg, H., Labad, J., Benedet, A. L., & Vilella, E. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101134
Sun, X., Feng, Y., Zhang, J., Tang, P., Xue, J., Yao, X., Li, W., Liu, L., & Liu, H. (2026) · Schizophrenia Research · doi:10.1016/j.schres.2026.07.022
Metadata
- Authors
- Sarró, S.
- Affiliations
- Hospital General de Granollers (ES)
- Corresponding author
- Sarró, S
- ORCID
- Sarró, S
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2004-06-01
- Volume
- 68
- Issue
- 2-3
- Pages
- 349-356
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2167486251
- Cited by
- 101
- References
- 39
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 5 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 7 · 2019: 12 · 2018: 5 · 2017: 7 · 2016: 4 · 2015: 6 · 2014: 4 · 2013: 4 · 2012: 1
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Keywords
- Calgary Depression Scale for Schizophrenia, Spanish translation
- MeSH terms
- Adult, Cross-Cultural Comparison, Depressive Disorder, Female, Humans, Language, Male, Psychiatric Status Rating Scales, Psychometrics, Schizophrenia, Schizophrenic Psychology, Spain, Translations, United States, Reproducibility of Results, Comorbidity, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
